1. Arisoy, O., & Oral, E. T. (2009). [Genetic studies of bipolar disorder: a review (Turkish)]. Turkish Journal of Psychiatry, 20(3), 282-293. [
PMID]
2. Barnett, J. H., & Smoller, J. W. (2009). The genetics of bipolar disorder. Neuroscience, 164(1), 331-43. doi: 10.1016/j.neuroscience.2009.03.080. [
DOI:10.1016/j.neuroscience.2009.03.080]
3. Bas, A., Forsberg, G., Hammarström, S., & Hammarström, M. L. (2004). Utility of the Housekeeping Genes 18S rRNA, β-Actin and Glyceraldehyde-3-Phosphate-Dehydrogenase for Normalization in Real-Time Quantitative Reverse Transcriptase-Polymerase Chain Reaction Analysis of Gene Expression in Human T Lymphocytes. Scandinavian Journal of Immunology, 59(6), 566-573. doi: 10.1111/j.0300-9475.2004.01440.x [
DOI:10.1111/j.0300-9475.2004.01440.x]
4. Charych, E. I., Liu, F., Moss, S. J., & Brandon, N. J. (2009). GABA(A) receptors and their associated proteins: Implications in the etiology and treatment of schizophrenia and related disorders. Neuropharmacology, 57(5-6), 481-95. doi: 10.1016/j.neuropharm.2009.07.027 [
DOI:10.1016/j.neuropharm.2009.07.027]
5. Cruceanu, C., Alda, M., Rouleau, G., & Turecki, G. (2011). Response to treatment in bipolar disorder. Current Opinion in Psychiatry, 24(1), 24-28. doi: 10.1097/YCO.0b013e328341352c [
DOI:10.1097/YCO.0b013e328341352c]
6. Domschke, K. (2013). Clinical and Molecular Genetics of Psychotic Depression. Schizophrenia Bulletin, 39(4), 766-75. doi: 10.1093/schbul/sbt040 [
DOI:10.1093/schbul/sbt040]
7. English, D., & Andersen, B. R. (1974). Single-step separation of red blood cells, granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. Journal of Immunological Methods, 5(3), 249-252. doi: 10.1016/0022-1759(74)90109-4 [
DOI:10.1016/0022-1759(74)90109-4]
8. Fatemi, S. H., Folsom, T. D., Rooney, R. J., & Thuras, P. D. (2013). Expression of GABAA α2-, β1- and receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder. Translational Psychiatry, 3(9), e303–e303. doi: 10.1038/tp.2013.6 [
DOI:10.1038/tp.2013.6]
9. Gonzalez-Burgos, G., Fish, K. N., & Lewis, D. A. (2011). GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia. Neural Plasticity, 2011, 2723184. doi: 10.1155/2011/723184 [
DOI:10.1155/2011/723184]
10. Luscher, B., Shen, Q., & Sahir, N. (2010). The GABAergic deficit hypothesis of major depressive disorder. Molecular Psychiatry, 16(4), 383-406. doi: 10.1038/mp.2010.120 [
DOI:10.1038/mp.2010.120]
11. Mohler, H. (2012). The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology, 62(1), 42-53. doi: 10.1016/j.neuropharm.2011.08.040 [
DOI:10.1016/j.neuropharm.2011.08.040]
12. Mundo, E., Zai, G., Lee, L., Parikh, S. V., & Kennedy, J. L. (2001). The 5HT1Dβ Receptor Gene in Bipolar Disorder: A Family-based Association Study. Neuropsychopharmacology, 25(4), 608-13. doi: 10.1016/S0893-133X(01)00259-7 [
DOI:10.1016/S0893-133X(01)00259-7]
13. Somogyi, P., Tamas, G., Lujan, R., & Buhl, E. H. (1998). Salient features of synaptic organisation in the cerebral cortex. Brain Research Reviews, 26(2-3), 113-35. doi: 10.1016/s0165-0173(97)00061-1 [
DOI:10.1016/S0165-0173(97)00061-1]
14. Wu, C., & Sun, D. (2015). GABA receptors in brain development, function, and injury. Metabolic Brain Disease, 30(2), 367-79. doi: 10.1007/s11011-014-9560-1 [
DOI:10.1007/s11011-014-9560-1]